ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
-1.03%
Bitcoin
62,477.88
5.68%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cascadian Therapeutics, Inc. (delisted) (CASC)

  7. Cascadian Therapeutics, Inc. (delisted) (CASC) Noticias

CASC

Cascadian Therapeutics, Inc. (CASC)

Cascadian Therapeutics, Inc. (delisted)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CASC
FechaHoraFuenteTítuloSímboloCompañía
11/04/201913:00Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/04/201815:54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
22/03/201813:12Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
22/03/201805:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
19/03/201814:17Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
13/03/201817:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201816:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201808:53Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201808:50Edgar (US Regulatory)Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201808:45Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201808:18Edgar (US Regulatory)(25-NSE)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201805:18Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
09/03/201805:13Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/03/201815:52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
16/02/201807:00Business WireSeattle Genetics Announces Expiration of Hart-Scott-Rodino Waiting PeriodNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/02/201816:39Business WireSeattle Genetics Commences Tender Offer for Cascadian Therapeutics, Inc.NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/02/201816:29Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/02/201816:28Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
07/02/201816:26Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
01/02/201808:31Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
31/01/201807:26PR Newswire (US)Cascadian (CASC) Alert: Johnson Fistel Investigates Proposed Sale of Cascadian Therapeutics, Inc.; Is $10.00 a Fair Price for...NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
31/01/201806:23Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
31/01/201805:30Business WireSeattle Genetics to Acquire Cascadian Therapeutics, Adding Late-Stage Breast Cancer Program to Its Oncology PipelineNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
04/01/201807:30GlobeNewswire Inc.Cascadian Therapeutics Announces 2018 Outlook and Recent ProgressNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
02/01/201807:30GlobeNewswire Inc.Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines AgencyNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
29/12/201715:10Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
13/12/201707:35GlobeNewswire Inc.Cascadian Therapeutics Added to the Nasdaq Biotechnology IndexNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
07/12/201715:05GlobeNewswire Inc.Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Can...NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/11/201716:04Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
08/11/201715:01GlobeNewswire Inc.Cascadian Therapeutics Reports Third Quarter 2017 Financial ResultsNASDAQ:CASCCascadian Therapeutics, Inc. (delisted)
 Showing the most relevant articles for your search:NASDAQ:CASC

Su Consulta Reciente

NASDAQ
TSLA
Tesla
NASDAQ
MSFT
Microsoft
FX
EURUSD
Euro vs US Dollar
NASDAQ
GOOGL
Alphabet
CCOM
US500
US 500
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
USOTC
RHHBY
Roche (QX)
NASDAQ
AMZN
Amazon.com
NYSE
CVX
Chevron
NYSE
JPM
JP Morgan Chase
CCOM
US30
US 30
NASDAQ
NVDA
NVIDIA
NASDAQ
AAPL
Apple
NYSE
KO
Coca Cola
FX
EURMXN
Euro vs MXN
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados